Final Flashcards
Work only by synergistic spontaneous recovery from NMB
Anticholinesterase (neostigmine/edrophonium)
Anticholinesterase MOA
Inactivate acetyl-cholinesterase in NMJ synaptic cleft
Neostigmine
Dose
Onset
Peak
Duration
0.04-0.07 mg/kg
Onset 1 min
Peak 9 min
Duration 20-30 min
Neostigmine metabolism and excretion
Metabolized in liver
80% excreted in urine in 24 hr
50% excreted unchanged
Muscarinic side effects of anticholinesterases (8)
NV Bradycardia Prolong QT Bronchoconstriction Salivary gland stimulation Miosis Increased GI tone
Ability to maintain head lift requires TOF ratio of
0.6
Ratio of TOF recovery required
0.9
Significant risk to pt recovery with NMB
Residual paralysis
Increase in NMB after a period of recovery
Recurarization
Recurirarization risk increased with
Respiratory acidosis and renal insufficiency
Sugammadex MOA
Encapsulates rocuronium rendering it unavailable to bind at NMJ
Sugammadex is a (chemical makeup)
G-cyclodextrin compound
Gamma cyclodextrin- 8 member sugar ring
Sugammadex is ineffective with
Benzylisoquinoliniums
Mechanism for ions and molecules bonding to metals and other ions
Chelation
Sugammadex properties (4)
Highly water soluble
PH 7.5
Osmolality 300-500mOsmol kg
Molecular wt 2178
Sugammadex metabolism and excretion
Not metabolized and renal excreted unchanged
Sugammadex can bind with drugs other than NMBs
Highest affinity after Roc for
Remifentanil
To re-establish NMB after reversal with sugammadex
Recommend benzylisoquinolinium
Roc will have less profound effect
Sugammadex and coags
limited (<1hr) increase in PTT and PT
Naturally occurring catecholamines
Epi
NE
Dopamine
Synthetic catecholamines
Isoproterenol
Dobutamine
Synthetic non-catecholamines
Ephedrine
Amphetamines
Phenylephrine
Methoxamine
Mephentermine
Alpha 1 couples to a Gq resulting in
Increased intracellular Calcium
Alpha 2 couples to Gi results in
Decreased cAMP activity
Beta receptors couple to Gs results in
Increase cAMP activity
Sympathomimetic drugs effects on adrenergic receptors where
Post ganglionic SNS
Preganglionic adrenergic neurons
Adrenergic receptors specifically bind to
Epi and NE for activation
Alpha 1 agonists
NE, phenylephrine, methoxamine
Alpha 1 antagonists
Phenoxybenzamine
Phentolamine (regifting)
Alpha 1 post synaptic effects
Vasoconstriction Mydriasis GI relaxation Contraction of GI and bladder Sphincters
Alpha 2 agonists
NE and epi
Selected agonist actions alpha 2
Smooth muscle contraction
NTS inhibition (can lead to sedation)
Alpha 2 agonists
Dexmedetomidine
Clonidine
Alpha 2 antagonists
Yohimbine
Where does alpha 2 work
Presynaptic- inhibition of NE
Post synaptic- plt aggregation
Hyperpolarization of CNS cells
Sedation
Beta 1 selected agonist actions
Increased myocardial contractility
Beta 1 agonists
Isoproterenol
Dobutamine
Epi
NE
Beta 1 antagonists
Metoprolol
Atenolol
Beta 2 selected agonist actions
Smooth muscle relaxation
Beta 2 agonists
Albuterol
Terbutaline
Isoproterenol
Beta 2 antagonists
Propanolol
Non-selective beta blocker
Propanolol
Beta 3 selected agonist actions
Lipolysis
6 steps of adrenergic transmission
Synthesis
Storage
Release (Ca mediated exocytosis)
Binding
Degradation
Recycling